On Thursday, ResMed Inc (NYSE:RMD) reported first-quarter adjusted EPS of $2.20, up 34% twelvemonth complete year, beating nan statement of $2.04.
The institution reported income of $1.224 billion, up 11%, beating nan statement of $1.18 billion, driven by accrued request for slumber devices and masks…
This communicative appeared connected benzinga.com, 2024-10-25 15:15:26.